Stenting versus Bypass Surgery for the Treatment of Left Main Coronary Artery Disease

다국어 초록 (Multilingual Abstract)

Based on data comparing coronary-artery bypass grafting (CABG) with medical therapy, the current guidelines
recommend CABG as the treatment of choice for patients with left main coronary artery (LMCA) disease.
Percutaneous coronary intervention (PCI) can be selectively performed in patients who are candidates for
revascularization but who are ineligible for CABG. Current evidence indicates that stenting results in mortality and
morbidity rates compared favorably with those seen after CABG. Data from several extensive registries and a large
clinical trial may have prompted many interventional cardiologists to choose PCI with stenting as an alternative
treatment option for such patients. In addition, these data may inform future guidelines and support the need for
well-designed, adequately powered, prospective, randomized trials comparing the two revascularization strategies.

다국어 초록 (Multilingual Abstract)

Based on data comparing coronary-artery bypass grafting (CABG) with medical therapy, the current guidelines
recommend CABG as the treatment of choice for patients with left main coronary artery (LMCA) disease.
Percutaneous coronary intervention (PCI) can be selectively performed in patients who are candidates for
revascularization but who are ineligible for CABG. Current evidence indicates that stenting results in mortality and
morbidity rates compared favorably with those seen after CABG. Data from several extensive registries and a large
clinical trial may have prompted many interventional cardiologists to choose PCI with stenting as an alternative
treatment option for such patients. In addition, these data may inform future guidelines and support the need for
well-designed, adequately powered, prospective, randomized trials comparing the two revascularization strategies.

참고문헌 (Reference)

1 Silvestri M, "Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures" 35 : 1543-1550, 2000

2 Black A, "Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection" 37 : 832-838, 2001

3 Laskey WK, "Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health" 115 : 2352-2357, 2007

4 Seung KB, "Stents versus coronary-artery bypass grafting for left main coronary artery disease" 358 : 1781-1792, 2008

5 Park SJ, "Stenting of unprotected left main coronary artery stenoses: immediate and late outcomes" 31 : 37-42, 1998

6 Mauri L, "Stent thrombosis in randomized clinical trials of drug-eluting stents" 356 : 1020-1029, 2007

7 Park SJ, "Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation" 45 : 351-356, 2005

8 Valgimigli M, "Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin- Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH)" 111 : 1383-1389, 2005

9 Stone GW, "Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents" 356 : 998-1008, 2007

10 Lagerqvist B, "SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden" 356 : 1009-1019, 2007

11 Taggart DP, "Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery" 51 : 885-892, 2008

12 Takagi T, "Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery" 106 : 698-702, 2002

13 Chieffo A, "Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience" 113 : 2542-2547, 2006

14 Serruys PW, "Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease" 360 : 961-972, 2009

15 Brar SS, "Longterm outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions" 51 : 2220-2227, 2008

16 Meliga E, "Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry" 51 : 2212-2219, 2008

17 Tan WA, "Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients" 104 : 1609-1614, 2001

18 Chieffo A, "Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry" 2008

19 Airoldi F, "Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment" 116 : 745-754, 2007

20 Park SJ, "Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance" 38 : 1054-1060, 2001

21 Daemen J, "Early and late coronary stent thrombosis of sirolimuseluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study" 369 : 667-678, 2007

22 Chieffo A, "Early and Mid-term results of drug-eluting stent implantation in unprotected left main" 111 : 791-795, 2005

23 Park SJ, "Drug-eluting stents for left main coronary artery stenosis: case selection and technical issues" 6 : 21-29, 2008

24 Sanmartin M, "Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease" 100 : 970-973, 2007

25 Lee MS, "Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease" 47 : 864-870, 2006

26 Palmerini T, "Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry)" 98 : 54-59, 2006

27 Eisenstein EL, "Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation" 297 : 159-168, 2007

28 Buszman PE, "Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization" 51 : 538-545, 2008

29 Smith SC Jr, "ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Interven-tion)" 113 : e166-e286, 2006

30 Eagle KA, "ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery)" 110 : e340-e437, 2004

31 Erglis A, "A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis" 50 : 491-497, 2007

32 Biondi-Zoccai GG, "A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drugeluting stenting for unprotected left main coronary artery disease" 155 : 274-283, 2008